Richard Lambie

Richard Lambie

Works at:

Tanner Pharma Group

Location in:

London, United Kingdom, United Kingdom

Richard Lambie

Richards connections

Currently

Works at:
Tanner Pharma Group
Location in:
London, United Kingdom, United Kingdom

Bio

A Pharmaceutical Professional with 10 years experience in staff management, marketing strategy, operations management, quality management and business development.

Provider of customer-focussed approaches in result-oriented environments.

Experienced, self-motivated leader with excellent organisational and communication skills.

Proven ability to think strategically, drive change to deliver top-line growth, develop & build strong relationships and make effective decisions.

Completed an Executive MBA at Imperial College Business School.

Richard has worked/studied in

  • Australia
  • New Zealand
  • United Kingdom

Richard speaks

  • English

Richard has experience in

  • Healthcare
  • Pharmaceuticals / Biotech

Join or Login to view the full profile

Only members of BusinessBecause can view full member profiles. Joining only takes one minute and you can sign in with your LinkedIn account...

Create a profile...


Work

2015 – present

Global Business Director- TannerCTS

Tanner Pharma Group , Brazil, United Kingdom, United States of America
  • Tanner Pharma is a fast growing speciality pharma company, which incorporates clinical trial supply, global access programs and licensing, acquisition and commercialisation. Leading pharmaceutical and biotech companies’ partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes and source comparator drugs for clinical trials and bioanalysis. At Tanner Pharma Group, it is our intention to build meaningful relationships with healthcare professionals who share our purpose of improving lives by providing customers with high quality products and services.
2014 – 2015
(Apr – Sep)

Strategy Consultant

Cello Health Consulting- formerly The MSI Consultancy
  • Since 2007 The MSI Consultancy has been a part of the global insight and strategic marketing group Cello Group plc. In an exciting new development, we’re now formally bringing together all Cello Group’s specialist health agencies under one new umbrella brand; Cello Health. As of March 3rd 2014, MSI will operate as Cello Health Consulting.
  • To find out more about Cello Health visit our Linked In Company Page or www.cellohealth.com.
  • Cello Health Consulting will continue to deliver the high quality strategic consulting that we’ve always prided ourselves on, but in addition we can now draw upon the wider capabilities of Cello Health Insight and Cello Health Communications - to help our clients maximise the potential of their assets, brands and organisations.
2012 – 2015

Business Development Executive

Durbin Plc , United Kingdom, United States of America
  • Global Clinical Trial Comparator and Early Access Programme Specialists
  • Global Clinical Trial Comparator and Managed Access Programme Specialists:
  • Effectively worked within International Business Development, primarily focusing on the Pharmaceutical and Biotechnology Industries across 180 countries including North America, Europe, South America and the BRIC-TM markets.
  • Consulted with large, medium and small Pharma/Biotech on various areas concerning Clinical Trial Supply, Clinical Operations & Protocol finalisation to ensure clients had the smoothest possible transition through their products clinical journey
  • Attended conferences and meetings globally, chairing round tables on best practice for Clinical Trial Supplies and Good Distribution Practice
  • GDP Supplier Assessment and Monitoring in both US and Europe through GDP/GMP certifications; also co-wrote the white paper: 'Advice on the new European GDP guidance'
  • Identified and proactively generated business revenue opportunities across the world within the Clinical Trial Supply and Managed Access Programs. Additionally promoted Durbin's distribution offerings, as well as 5 other operational divisions.
  • Brand Development and Marketing of the Durbin offering within CTS and MAP
2011 – 2012
(Jul – Feb)

Contract Medical Writer/Editor

Oberon Ltd. , United Kingdom
  • Editing, compiling and writing/editing new medical trials for publication to a high standard for admission into medical journals.
  • Created strategic meta-analysis presentations offering commercial insite into new to launch products versus leading competitors allowing the most impactful comparisons to be used in launch strategies.
  • Compiled and edited trials focusing on Cardiovascular, Endocrine and Oncologic conditions for Boehringer Ingelheim, Sanofi Aventis and Roche.
2009 – 2011

Sales and Marketing Roles - Pharmaceuticals

Abbott Laboratories , New Zealand
  • Conceptualised direct-to-consumer (DTC) Reductil and Brufen advertising:
  • Won the “Brufen Brand Challenge” award for 2011 for highest sales growth, results to target and successful marketing campaign in the Asia/Pacific/Africa region.
  • Created Brufen relaunch materials allowing the sales team to gain maximum exposure and resonance during this critical time.
  • Doubling sales of Brufen during Q4 2010 after successful re-launch.
  • Successfully trained new sales representatives in Brufen SR (ibuprofen): Pharmacodynamics, Kinetics & Formulation.
  • Generated excellent relationships with new & existing clients by maximizing KOL relationships.
  • Provided annual talks to New Zealand Dental School final year students and post-graduate registrars.
  • Won the “Reductil Brand Challenge” award for 2010 for highest sales growth, results to target and successful marketing campaign in the Asia/Pacific/Africa region.
  • Created Key Marketing Strategy for 2010 for Reductil which increased stakeholder and patient engagement while reducing cost overheads.

Work

2015 – present

Global Business Director- TannerCTS

Tanner Pharma Group , Brazil, United Kingdom, United States of America
  • Tanner Pharma is a fast growing speciality pharma company, which incorporates clinical trial supply, global access programs and licensing, acquisition and commercialisation. Leading pharmaceutical and biotech companies’ partner with Tanner Pharma to license and commercialize their products in challenging international markets, develop and manage their Global Access Programmes and source comparator drugs for clinical trials and bioanalysis. At Tanner Pharma Group, it is our intention to build meaningful relationships with healthcare professionals who share our purpose of improving lives by providing customers with high quality products and services.
2014 – 2015
(Apr – Sep)

Strategy Consultant

Cello Health Consulting- formerly The MSI Consultancy
  • Since 2007 The MSI Consultancy has been a part of the global insight and strategic marketing group Cello Group plc. In an exciting new development, we’re now formally bringing together all Cello Group’s specialist health agencies under one new umbrella brand; Cello Health. As of March 3rd 2014, MSI will operate as Cello Health Consulting.
  • To find out more about Cello Health visit our Linked In Company Page or www.cellohealth.com.
  • Cello Health Consulting will continue to deliver the high quality strategic consulting that we’ve always prided ourselves on, but in addition we can now draw upon the wider capabilities of Cello Health Insight and Cello Health Communications - to help our clients maximise the potential of their assets, brands and organisations.
2012 – 2015

Business Development Executive

Durbin Plc , United Kingdom, United States of America
  • Global Clinical Trial Comparator and Early Access Programme Specialists
  • Global Clinical Trial Comparator and Managed Access Programme Specialists:
  • Effectively worked within International Business Development, primarily focusing on the Pharmaceutical and Biotechnology Industries across 180 countries including North America, Europe, South America and the BRIC-TM markets.
  • Consulted with large, medium and small Pharma/Biotech on various areas concerning Clinical Trial Supply, Clinical Operations & Protocol finalisation to ensure clients had the smoothest possible transition through their products clinical journey
  • Attended conferences and meetings globally, chairing round tables on best practice for Clinical Trial Supplies and Good Distribution Practice
  • GDP Supplier Assessment and Monitoring in both US and Europe through GDP/GMP certifications; also co-wrote the white paper: 'Advice on the new European GDP guidance'
  • Identified and proactively generated business revenue opportunities across the world within the Clinical Trial Supply and Managed Access Programs. Additionally promoted Durbin's distribution offerings, as well as 5 other operational divisions.
  • Brand Development and Marketing of the Durbin offering within CTS and MAP
2011 – 2012
(Jul – Feb)

Contract Medical Writer/Editor

Oberon Ltd. , United Kingdom
  • Editing, compiling and writing/editing new medical trials for publication to a high standard for admission into medical journals.
  • Created strategic meta-analysis presentations offering commercial insite into new to launch products versus leading competitors allowing the most impactful comparisons to be used in launch strategies.
  • Compiled and edited trials focusing on Cardiovascular, Endocrine and Oncologic conditions for Boehringer Ingelheim, Sanofi Aventis and Roche.
2009 – 2011

Sales and Marketing Roles - Pharmaceuticals

Abbott Laboratories , New Zealand
  • Conceptualised direct-to-consumer (DTC) Reductil and Brufen advertising:
  • Won the “Brufen Brand Challenge” award for 2011 for highest sales growth, results to target and successful marketing campaign in the Asia/Pacific/Africa region.
  • Created Brufen relaunch materials allowing the sales team to gain maximum exposure and resonance during this critical time.
  • Doubling sales of Brufen during Q4 2010 after successful re-launch.
  • Successfully trained new sales representatives in Brufen SR (ibuprofen): Pharmacodynamics, Kinetics & Formulation.
  • Generated excellent relationships with new & existing clients by maximizing KOL relationships.
  • Provided annual talks to New Zealand Dental School final year students and post-graduate registrars.
  • Won the “Reductil Brand Challenge” award for 2010 for highest sales growth, results to target and successful marketing campaign in the Asia/Pacific/Africa region.
  • Created Key Marketing Strategy for 2010 for Reductil which increased stakeholder and patient engagement while reducing cost overheads.

Education

2013 – 2014

Imperial College Business School

Master of Business Administration (MBA)
2003 – 2006

University of Otago

Bachelor of Pharmacy

Achievements

  • Reductil Brand Challenge” award for the Asia/Pacific/Africa region
  • “Brufen Brand Challenge” award in the Asia/Pacific/Africa region
  • Winner- I&EStart;! Challenge- Imperial College Business School

Additional Info

Nationality:
  • New Zealander